UCSF Speakers Announced for 2016 Personalized Medicine World Conference

The lineup is finalized for the 2016 Personalized Medicine World Conference, with nine scheduled talks by UCSF leaders and faculty.

The conference, co-sponsored this year by UCSF, is the premier gathering in precision medicine, attracting experts and executives in health care, biotechnology, venture capital, technology and government.

This year’s program kicks off with program chair Atul Butte, MD, PhD, who leads the UCSF Institute for Computational Health Sciences as well as the California Initiative to Advance Precision Medicine.

Personalized Medicine World Conference

January 24 to 27, 2016
Computer History Museum
Mountain View

The opening session also will include remarks by UCSF Chancellor Sam Hawgood, MBBS, who co-authored the article, “Precision Medicine: Beyond the Inflection Point,” published in Science Translational Medicine in August.

One of this year’s PMWC Luminary Awards will be given to Laura Esserman, MD, for her work in precision breast cancer medicine. The annual award recognizes recent contributions of preeminent figures who have accelerated personalized medicine into the clinical marketplace.

Here is the full lineup of session speakers from UCSF:

Atul Butte, MD, PhD, principal investigator of California Initiative to Advance Precision Medicine
Topic: The Give and Take Between Government & Personalized Medicine

Charles Chiu, MD, PhD, director of UCSF-Abbott Viral Diagnostics and Discovery Center
Topic: Changing the Point-of-Care Setting for Precision Medicine in Infectious Diseases

Laura Esserman, MD, surgeon and breast cancer specialist
Topic: Using Biomarkers and Diagnostics to Impact Care

Robert Lustig, MD, professor of Pediatrics
Topic: Genes & Environment in Metabolic Disease

Steve Miller, MD, PhD, associate professor of Laboratory Medicine
Topic: Precision Diagnosis of Infections by Metagenomic Sequencing

Minnie Sarwal, MD, PhD, professor of Surgery
Topic: The SORT Assay for Diagnosis of Organ Transplant Rejection

John Witte, PhD, MS, professor of Epidemiology & Biostatistics
Topic: DNA-based Liquid Biopsies for Early Tumor Detection

Alan Wu, PhD, chief of Clinical Chemistry and Toxicology at Zuckerberg San Francisco General Hospital and Trauma Center
Topic: Promoting Pharmacogenomics to the Public

Keith Yamamoto, PhD, vice chancellor of Science Policy and Strategy
Topic: Precision Medicine: Beyond The Inflection Point

See the full schedule »